Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) EPS (Weighted Average and Diluted): 2019-2023

Historic EPS (Weighted Average and Diluted) for ADC Therapeutics (ADCT) over the last 4 years, with Sep 2023 value amounting to -$0.57.

  • ADC Therapeutics' EPS (Weighted Average and Diluted) fell 187.69% to -$0.57 in Q3 2023 from the same period last year, while for Sep 2023 it was -$0.73, marking a year-over-year decrease of 157.94%. This contributed to the annual value of -$1.99 for FY2022, which is 33.67% up from last year.
  • As of Q3 2023, ADC Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.57, which was up 5.00% from -$0.60 recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' EPS (Weighted Average and Diluted) registered a high of $2.01 during Q2 2020, and its lowest value of -$0.85 during Q1 2020.
  • For the 3-year period, ADC Therapeutics' EPS (Weighted Average and Diluted) averaged around $0.28, with its median value being $0.65 (2022).
  • Per our database at Business Quant, ADC Therapeutics' EPS (Weighted Average and Diluted) skyrocketed by 458.93% in 2020 and then crashed by 187.69% in 2023.
  • Quarterly analysis of 5 years shows ADC Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.62 in 2019, then soared by 146.77% to $0.29 in 2020, then spiked by 220.69% to -$0.45 in 2021, then surged by 33.33% to -$0.30 in 2022, then tumbled by 187.69% to -$0.57 in 2023.
  • Its last three reported values are -$0.57 in Q3 2023, -$0.60 for Q2 2023, and $0.74 during Q1 2023.